Breathall is a Turkey-based startup that focuses on developing physiotherapy solutions for patients with acute and chronic respiratory diseases. The company's flagship product, the AirCircle physiotherapy vest, is designed to ensure that manual chest physiotherapy is performed correctly and effectively by caregivers in each session. To complement this, the AirCircle app is designed to make physiotherapy sessions clear and practical for all users.
Breathall's solutions, particularly the implementation of chest physiotherapy (CPT), have the potential to significantly improve the lives of patients with respiratory diseases such as Asthma, COPD, Pneumonia, Bronchiectasis, and Cystic Fibrosis. The company emphasizes that regular monitoring of the session parameters can help reveal the effectiveness of physiotherapy treatments, make early detection of wrong implementations, and help patients avoid unnecessary hospital visits.
One notable aspect of Breathall's technology is the incorporation of advanced pressure sensor technology in the AirCircle, which accurately determines the accuracy and effectiveness of the session parameters. This feature contributes to the overall goal of ensuring that physiotherapy is performed optimally for each patient.
Founded in 2020, Breathall operates in the Health Care, Health and Wellness, and Medical Devices industries. While specific details regarding the last investment and investors are currently unavailable, Breathall's focus on improving the quality of life for individuals with respiratory diseases positions them well within the ever-growing health and wellness market.
There is no investment information
No recent news or press coverage available for Breathall.